NCT06846983 Peripheral Perfusion Index as an Early Predictor of Successful Caudal Block in Pediatric Patients Undergoing Lower Abdominopelvic Surgeries Under General Anesthesia
| NCT ID | NCT06846983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Peripheral Perfusion Index |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-01-02 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-01-02 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess early predictability of peripheral perfusion index to success of caudal block in pediatric patients undergoing lower abdominopelvic surgeries
Eligibility Criteria
Inclusion Criteria: * Pediatric patients aging between 1-5 years of both sexes. * Pediatric patients posted for elective lower abdominopelvic surgeries under general anesthesia (duration of surgery under 120 minutes). * ASA physical status classes I - II. Exclusion Criteria: * Guardian's refusal of procedure or participation in the study. * ASA classes III or above. * Infection at site of injection. * Neurological diseases and disorders such as (neuromuscular disease, cerebral palsy, spinal dysraphism …etc.) * Coagulopathy and bleeding disorders. * Hypersensitivity to the study medications. * Patients receiving vasoactive drugs or beta blockers. * Patients undergoing emergency surgery. * Patients in active clinical sepsis.
Contact & Investigator
Omar Mohamed Taha Abdallah El-Safty, M.B.B.CH., MD.
STUDY CHAIR
Faculty of Medicine, Ain Shams University
Frequently Asked Questions
Who can join the NCT06846983 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 5 Years, studying Peripheral Perfusion Index. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06846983 currently recruiting?
Yes, NCT06846983 is actively recruiting participants. Contact the research team at mohamed.mohsen@med.asu.edu.eg for enrollment information.
Where is the NCT06846983 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06846983 clinical trial?
NCT06846983 is sponsored by Ain Shams University. The principal investigator is Omar Mohamed Taha Abdallah El-Safty, M.B.B.CH., MD. at Faculty of Medicine, Ain Shams University. The trial plans to enroll 60 participants.